XOMA Co. (NASDAQ:XOMAP) Short Interest Down 50.0% in October

XOMA Co. (NASDAQ:XOMAP) was the target of a large decline in short interest in the month of October. As of October 15th, there was short interest totalling 2,900 shares, a decline of 50.0% from the September 30th total of 5,800 shares. Based on an average daily volume of 2,000 shares, the days-to-cover ratio is currently 1.5 days.

XOMA Stock Up 0.7 %

Shares of XOMAP stock opened at $26.49 on Monday. The company’s 50-day simple moving average is $25.77 and its 200-day simple moving average is $25.46. XOMA has a one year low of $21.40 and a one year high of $26.51.

About XOMA

XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets.